NCT00667121 2025-02-14
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Mayo Clinic
Completed
Mayo Clinic
Hospital Universitari de Bellvitge
UNC Lineberger Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Kalaco Scientific, Inc.